世界の鎮痙薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antispasmodics Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3839
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、鎮痙薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジシクロミン塩酸塩、ロペラミド塩酸塩、その他）、用途別市場規模（病院、ホームケア、専門診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・鎮痙薬の市場動向
・企業の競争状況、市場シェア
・鎮痙薬の種類別市場規模と予測2016-2027（ジシクロミン塩酸塩、ロペラミド塩酸塩、その他）
・鎮痙薬の用途別市場規模と予測2016-2027（病院、ホームケア、専門診療所、その他）
・鎮痙薬の北米市場規模2016-2027（アメリカ、カナダ）
・鎮痙薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・鎮痙薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・鎮痙薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・鎮痙薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Allergan、Hikma Pharmaceutical、Lannett、Mylan、Nexus Pharmaceuticals、Akorn、Aurobindo Pharma、Daiichi Sankyo、Fresenius Kabi、Shanghai Fosun Pharmaceutical（Group）、SunGen Pharma）
・結論

It is a drug that suppresses muscle spasms, a type of antispasmodic used for smooth muscle contraction, especially in the tubular organs of the gastrointestinal tract.

Market Analysis and Insights: Global Antispasmodics Drug Market
The global Antispasmodics Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antispasmodics Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antispasmodics Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antispasmodics Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antispasmodics Drug market.

Global Antispasmodics Drug Scope and Market Size
Antispasmodics Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antispasmodics Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Dicyclomine Hydrochloride
Loperamide Hydrochloride
Others

Segment by Application
Hospital
Homecare
Specialty Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan
Hikma Pharmaceutical
Lannett
Mylan
Nexus Pharmaceuticals
Akorn
Aurobindo Pharma
Daiichi Sankyo
Fresenius Kabi
Shanghai Fosun Pharmaceutical（Group）
SunGen Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antispasmodics Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Dicyclomine Hydrochloride
1.2.3 Loperamide Hydrochloride
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antispasmodics Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Specialty Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antispasmodics Drug Market Perspective (2016-2027)
2.2 Antispasmodics Drug Growth Trends by Regions
2.2.1 Antispasmodics Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antispasmodics Drug Historic Market Share by Regions (2016-2021)
2.2.3 Antispasmodics Drug Forecasted Market Size by Regions (2022-2027)
2.3 Antispasmodics Drug Industry Dynamic
2.3.1 Antispasmodics Drug Market Trends
2.3.2 Antispasmodics Drug Market Drivers
2.3.3 Antispasmodics Drug Market Challenges
2.3.4 Antispasmodics Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antispasmodics Drug Players by Revenue
3.1.1 Global Top Antispasmodics Drug Players by Revenue (2016-2021)
3.1.2 Global Antispasmodics Drug Revenue Market Share by Players (2016-2021)
3.2 Global Antispasmodics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antispasmodics Drug Revenue
3.4 Global Antispasmodics Drug Market Concentration Ratio
3.4.1 Global Antispasmodics Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antispasmodics Drug Revenue in 2020
3.5 Antispasmodics Drug Key Players Head office and Area Served
3.6 Key Players Antispasmodics Drug Product Solution and Service
3.7 Date of Enter into Antispasmodics Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antispasmodics Drug Breakdown Data by Type
4.1 Global Antispasmodics Drug Historic Market Size by Type (2016-2021)
4.2 Global Antispasmodics Drug Forecasted Market Size by Type (2022-2027)

5 Antispasmodics Drug Breakdown Data by Application
5.1 Global Antispasmodics Drug Historic Market Size by Application (2016-2021)
5.2 Global Antispasmodics Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antispasmodics Drug Market Size (2016-2027)
6.2 North America Antispasmodics Drug Market Size by Type
6.2.1 North America Antispasmodics Drug Market Size by Type (2016-2021)
6.2.2 North America Antispasmodics Drug Market Size by Type (2022-2027)
6.2.3 North America Antispasmodics Drug Market Size by Type (2016-2027)
6.3 North America Antispasmodics Drug Market Size by Application
6.3.1 North America Antispasmodics Drug Market Size by Application (2016-2021)
6.3.2 North America Antispasmodics Drug Market Size by Application (2022-2027)
6.3.3 North America Antispasmodics Drug Market Size by Application (2016-2027)
6.4 North America Antispasmodics Drug Market Size by Country
6.4.1 North America Antispasmodics Drug Market Size by Country (2016-2021)
6.4.2 North America Antispasmodics Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Antispasmodics Drug Market Size (2016-2027)
7.2 Europe Antispasmodics Drug Market Size by Type
7.2.1 Europe Antispasmodics Drug Market Size by Type (2016-2021)
7.2.2 Europe Antispasmodics Drug Market Size by Type (2022-2027)
7.2.3 Europe Antispasmodics Drug Market Size by Type (2016-2027)
7.3 Europe Antispasmodics Drug Market Size by Application
7.3.1 Europe Antispasmodics Drug Market Size by Application (2016-2021)
7.3.2 Europe Antispasmodics Drug Market Size by Application (2022-2027)
7.3.3 Europe Antispasmodics Drug Market Size by Application (2016-2027)
7.4 Europe Antispasmodics Drug Market Size by Country
7.4.1 Europe Antispasmodics Drug Market Size by Country (2016-2021)
7.4.2 Europe Antispasmodics Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antispasmodics Drug Market Size (2016-2027)
8.2 Asia-Pacific Antispasmodics Drug Market Size by Type
8.2.1 Asia-Pacific Antispasmodics Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antispasmodics Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antispasmodics Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Antispasmodics Drug Market Size by Application
8.3.1 Asia-Pacific Antispasmodics Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antispasmodics Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antispasmodics Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Antispasmodics Drug Market Size by Region
8.4.1 Asia-Pacific Antispasmodics Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antispasmodics Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antispasmodics Drug Market Size (2016-2027)
9.2 Latin America Antispasmodics Drug Market Size by Type
9.2.1 Latin America Antispasmodics Drug Market Size by Type (2016-2021)
9.2.2 Latin America Antispasmodics Drug Market Size by Type (2022-2027)
9.2.3 Latin America Antispasmodics Drug Market Size by Type (2016-2027)
9.3 Latin America Antispasmodics Drug Market Size by Application
9.3.1 Latin America Antispasmodics Drug Market Size by Application (2016-2021)
9.3.2 Latin America Antispasmodics Drug Market Size by Application (2022-2027)
9.3.3 Latin America Antispasmodics Drug Market Size by Application (2016-2027)
9.4 Latin America Antispasmodics Drug Market Size by Country
9.4.1 Latin America Antispasmodics Drug Market Size by Country (2016-2021)
9.4.2 Latin America Antispasmodics Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antispasmodics Drug Market Size (2016-2027)
10.2 Middle East & Africa Antispasmodics Drug Market Size by Type
10.2.1 Middle East & Africa Antispasmodics Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antispasmodics Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antispasmodics Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Antispasmodics Drug Market Size by Application
10.3.1 Middle East & Africa Antispasmodics Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antispasmodics Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antispasmodics Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Antispasmodics Drug Market Size by Country
10.4.1 Middle East & Africa Antispasmodics Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antispasmodics Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Antispasmodics Drug Introduction
11.1.4 Allergan Revenue in Antispasmodics Drug Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Hikma Pharmaceutical
11.2.1 Hikma Pharmaceutical Company Details
11.2.2 Hikma Pharmaceutical Business Overview
11.2.3 Hikma Pharmaceutical Antispasmodics Drug Introduction
11.2.4 Hikma Pharmaceutical Revenue in Antispasmodics Drug Business (2016-2021)
11.2.5 Hikma Pharmaceutical Recent Development
11.3 Lannett
11.3.1 Lannett Company Details
11.3.2 Lannett Business Overview
11.3.3 Lannett Antispasmodics Drug Introduction
11.3.4 Lannett Revenue in Antispasmodics Drug Business (2016-2021)
11.3.5 Lannett Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Antispasmodics Drug Introduction
11.4.4 Mylan Revenue in Antispasmodics Drug Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 Nexus Pharmaceuticals
11.5.1 Nexus Pharmaceuticals Company Details
11.5.2 Nexus Pharmaceuticals Business Overview
11.5.3 Nexus Pharmaceuticals Antispasmodics Drug Introduction
11.5.4 Nexus Pharmaceuticals Revenue in Antispasmodics Drug Business (2016-2021)
11.5.5 Nexus Pharmaceuticals Recent Development
11.6 Akorn
11.6.1 Akorn Company Details
11.6.2 Akorn Business Overview
11.6.3 Akorn Antispasmodics Drug Introduction
11.6.4 Akorn Revenue in Antispasmodics Drug Business (2016-2021)
11.6.5 Akorn Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Details
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Antispasmodics Drug Introduction
11.7.4 Aurobindo Pharma Revenue in Antispasmodics Drug Business (2016-2021)
11.7.5 Aurobindo Pharma Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Details
11.8.2 Daiichi Sankyo Business Overview
11.8.3 Daiichi Sankyo Antispasmodics Drug Introduction
11.8.4 Daiichi Sankyo Revenue in Antispasmodics Drug Business (2016-2021)
11.8.5 Daiichi Sankyo Recent Development
11.9 Fresenius Kabi
11.9.1 Fresenius Kabi Company Details
11.9.2 Fresenius Kabi Business Overview
11.9.3 Fresenius Kabi Antispasmodics Drug Introduction
11.9.4 Fresenius Kabi Revenue in Antispasmodics Drug Business (2016-2021)
11.9.5 Fresenius Kabi Recent Development
11.10 Shanghai Fosun Pharmaceutical（Group）
11.10.1 Shanghai Fosun Pharmaceutical（Group） Company Details
11.10.2 Shanghai Fosun Pharmaceutical（Group） Business Overview
11.10.3 Shanghai Fosun Pharmaceutical（Group） Antispasmodics Drug Introduction
11.10.4 Shanghai Fosun Pharmaceutical（Group） Revenue in Antispasmodics Drug Business (2016-2021)
11.10.5 Shanghai Fosun Pharmaceutical（Group） Recent Development
11.11 SunGen Pharma
11.11.1 SunGen Pharma Company Details
11.11.2 SunGen Pharma Business Overview
11.11.3 SunGen Pharma Antispasmodics Drug Introduction
11.11.4 SunGen Pharma Revenue in Antispasmodics Drug Business (2016-2021)
11.11.5 SunGen Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antispasmodics Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Dicyclomine Hydrochloride
Table 3. Key Players of Loperamide Hydrochloride
Table 4. Key Players of Others
Table 5. Global Antispasmodics Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Antispasmodics Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antispasmodics Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Antispasmodics Drug Market Share by Regions (2016-2021)
Table 9. Global Antispasmodics Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Antispasmodics Drug Market Share by Regions (2022-2027)
Table 11. Antispasmodics Drug Market Trends
Table 12. Antispasmodics Drug Market Drivers
Table 13. Antispasmodics Drug Market Challenges
Table 14. Antispasmodics Drug Market Restraints
Table 15. Global Antispasmodics Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Antispasmodics Drug Market Share by Players (2016-2021)
Table 17. Global Top Antispasmodics Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antispasmodics Drug as of 2020)
Table 18. Ranking of Global Top Antispasmodics Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Antispasmodics Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antispasmodics Drug Product Solution and Service
Table 22. Date of Enter into Antispasmodics Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antispasmodics Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Antispasmodics Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Antispasmodics Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Antispasmodics Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Antispasmodics Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Antispasmodics Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Antispasmodics Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Antispasmodics Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Antispasmodics Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Antispasmodics Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Antispasmodics Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Antispasmodics Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Antispasmodics Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Antispasmodics Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Antispasmodics Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Antispasmodics Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Antispasmodics Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Antispasmodics Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Antispasmodics Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Antispasmodics Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Antispasmodics Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Antispasmodics Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antispasmodics Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antispasmodics Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antispasmodics Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Antispasmodics Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Antispasmodics Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Antispasmodics Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Antispasmodics Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Antispasmodics Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Antispasmodics Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Antispasmodics Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Antispasmodics Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Antispasmodics Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antispasmodics Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antispasmodics Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antispasmodics Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Antispasmodics Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Antispasmodics Drug Product
Table 65. Allergan Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Hikma Pharmaceutical Company Details
Table 68. Hikma Pharmaceutical Business Overview
Table 69. Hikma Pharmaceutical Antispasmodics Drug Product
Table 70. Hikma Pharmaceutical Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 71. Hikma Pharmaceutical Recent Development
Table 72. Lannett Company Details
Table 73. Lannett Business Overview
Table 74. Lannett Antispasmodics Drug Product
Table 75. Lannett Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 76. Lannett Recent Development
Table 77. Mylan Company Details
Table 78. Mylan Business Overview
Table 79. Mylan Antispasmodics Drug Product
Table 80. Mylan Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 81. Mylan Recent Development
Table 82. Nexus Pharmaceuticals Company Details
Table 83. Nexus Pharmaceuticals Business Overview
Table 84. Nexus Pharmaceuticals Antispasmodics Drug Product
Table 85. Nexus Pharmaceuticals Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 86. Nexus Pharmaceuticals Recent Development
Table 87. Akorn Company Details
Table 88. Akorn Business Overview
Table 89. Akorn Antispasmodics Drug Product
Table 90. Akorn Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 91. Akorn Recent Development
Table 92. Aurobindo Pharma Company Details
Table 93. Aurobindo Pharma Business Overview
Table 94. Aurobindo Pharma Antispasmodics Drug Product
Table 95. Aurobindo Pharma Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 96. Aurobindo Pharma Recent Development
Table 97. Daiichi Sankyo Company Details
Table 98. Daiichi Sankyo Business Overview
Table 99. Daiichi Sankyo Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 100. Daiichi Sankyo Recent Development
Table 101. Fresenius Kabi Company Details
Table 102. Fresenius Kabi Business Overview
Table 103. Fresenius Kabi Antispasmodics Drug Product
Table 104. Fresenius Kabi Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 105. Fresenius Kabi Recent Development
Table 106. Shanghai Fosun Pharmaceutical（Group） Company Details
Table 107. Shanghai Fosun Pharmaceutical（Group） Business Overview
Table 108. Shanghai Fosun Pharmaceutical（Group） Antispasmodics Drug Product
Table 109. Shanghai Fosun Pharmaceutical（Group） Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 110. Shanghai Fosun Pharmaceutical（Group） Recent Development
Table 111. SunGen Pharma Company Details
Table 112. SunGen Pharma Business Overview
Table 113. SunGen Pharma Antispasmodics Drug Product
Table 114. SunGen Pharma Revenue in Antispasmodics Drug Business (2016-2021) & (US$ Million)
Table 115. SunGen Pharma Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antispasmodics Drug Market Share by Type: 2020 VS 2027
Figure 2. Dicyclomine Hydrochloride Features
Figure 3. Loperamide Hydrochloride Features
Figure 4. Others Features
Figure 5. Global Antispasmodics Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Homecare Case Studies
Figure 8. Specialty Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Antispasmodics Drug Report Years Considered
Figure 11. Global Antispasmodics Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Antispasmodics Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Antispasmodics Drug Market Share by Regions: 2020 VS 2027
Figure 14. Global Antispasmodics Drug Market Share by Regions (2022-2027)
Figure 15. Global Antispasmodics Drug Market Share by Players in 2020
Figure 16. Global Top Antispasmodics Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antispasmodics Drug as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Antispasmodics Drug Revenue in 2020
Figure 18. Global Antispasmodics Drug Revenue Market Share by Type (2016-2021)
Figure 19. Global Antispasmodics Drug Revenue Market Share by Type (2022-2027)
Figure 20. North America Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Antispasmodics Drug Market Share by Type (2016-2027)
Figure 22. North America Antispasmodics Drug Market Share by Application (2016-2027)
Figure 23. North America Antispasmodics Drug Market Share by Country (2016-2027)
Figure 24. United States Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antispasmodics Drug Market Share by Type (2016-2027)
Figure 28. Europe Antispasmodics Drug Market Share by Application (2016-2027)
Figure 29. Europe Antispasmodics Drug Market Share by Country (2016-2027)
Figure 30. Germany Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antispasmodics Drug Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Antispasmodics Drug Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Antispasmodics Drug Market Share by Region (2016-2027)
Figure 40. China Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antispasmodics Drug Market Share by Type (2016-2027)
Figure 48. Latin America Antispasmodics Drug Market Share by Application (2016-2027)
Figure 49. Latin America Antispasmodics Drug Market Share by Country (2016-2027)
Figure 50. Mexico Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antispasmodics Drug Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Antispasmodics Drug Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Antispasmodics Drug Market Share by Country (2016-2027)
Figure 56. Turkey Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Antispasmodics Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Allergan Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 60. Hikma Pharmaceutical Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 61. Lannett Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 62. Mylan Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 63. Nexus Pharmaceuticals Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 64. Akorn Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 65. Aurobindo Pharma Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 66. Daiichi Sankyo Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 67. Fresenius Kabi Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 68. Shanghai Fosun Pharmaceutical（Group） Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 69. SunGen Pharma Revenue Growth Rate in Antispasmodics Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の抗痙攣薬市場規模・現状・予測（2021年-2027年）

Global Antispasmodics Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3840 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、抗痙攣薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、その他）、用途別市場規模（病院、専門診療所、ホームケア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の向精神薬市場規模・現状・予測（2021年-2027年）

Global Psychotropic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4785 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界の抗レトロウイルス薬市場規模・現状・予測（2021年-2027年）

Global Antiretroviral Drug Market Size, Status and Forecast 2021-2027
QFJ1-5589 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、抗レトロウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（多剤併用、NRTI、NNRTI、プロテアーゼ阻害剤、その他）、用途別市場規模（病院、製薬会社、その他）、主要地域別市場規模（北米、アメ...

世界のアテローム性動脈硬化症薬市場規模・現状・予測（2021年-2027年）

Global Atherosclerosis Drug Market Size, Status and Forecast 2021-2027
QFJ1-3865 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗血小板薬、コレステロール低下薬、フィブリン酸＆オメガ-3脂肪酸誘導体、その他）、用途別市場規模（小売薬局、病院薬局、オンライン...

世界の皮膚放射線傷害治療薬市場規模・現状・予測（2021年-2027年）

Global Cutaneous Radiation Injury Drug Market Size, Status and Forecast 2021-2027
QFJ1-4082 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、皮膚放射線傷害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界のB型肝炎治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Drug Market Size, Status and Forecast 2021-2027
QFJ1-5776 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、B型肝炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）、...

世界の抗痙攣薬市場規模・現状・予測（2021年-2027年） One type of antispasmodic is used for smooth muscle contraction, especially in the tubular organs of the gastrointestinal tract. The effect is to prevent cramps in the stomach, intestines or bladder. Market Analysis and Insights: Global Antispasmodics Drugs Market The global Antispasmodics Drugs mar…
世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
世界の向精神薬市場規模・現状・予測（2021年-2027年） The majority of essential psychotropic drugs are indicated to treat symptoms of mental disorders, slow down course of mental disorders, diminish disability and avoid relapse in a patient. Market Analysis and Insights: Global Psychotropic Drug Market The global Psychotropic Drug market size is projec…
世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年） Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. Market Analysis and Insights: Global Neuraminidase Inhibitors Drug Market The global Neuraminidase Inhibitors Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…